Entadfi
Product Images NDC 69681-125
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Entadfi (NDC 69681-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Veru Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Of Bottle Label (5 mg/5 mg)
Image Of Chemical Structure Of Tadalafil (Cs1)
Image Of Chemical Structure Of Finasteride (Cs2)
Image Of Mean Maximal Change In Blood Pressure (tadalafil Minus Placebo, Point Estimate With 90% Ci) In Response To Sublingual Nitroglycerin At 2 (supine Only), 4, 8, 24, 48, 72, And 96 Hours After The Last Dose Of Tadalafil 20 mg Or Placebo (Fig1)
Image Of Doxazosin Study 1: Mean Change From Baseline In Systolic Blood Pressure (Fig2)
Image Of Doxazosin Study 2 (part C): Mean Change From Time-matched Baseline In Systolic Blood Pressure (Fig3)
Image Of Mean Total Ipss Changes By Visit In Bph Patients Taking Tadalafil Together With Finasteride (Fig4)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.